GGrantIndex
← Leaderboards

University Of Cape Town Lung Institute

Cape Town

Compare ↔
$2,191,470
Total funding
2
Grants

Funding over time

peak $582.8K · FY2018–22
$1M$750K$500K$250K$0
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$2,191,470 · 2

By mechanism

R01$1,543,513 · 1
K43$647,957 · 1

Investigators at University Of Cape Town Lung Institute

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

Not enough data

Largest grants

The Missing Millions: Identification and infectiousness of undiagnosed tuberculosis cases in the community (the MI-TB study)$425,645
R01 · FY2019 · AI
The Missing Millions: Identification and infectiousness of undiagnosed tuberculosis cases in the community (the MI-TB study)$388,431
R01 · FY2021 · AI
The Missing Millions: Identification and infectiousness of undiagnosed tuberculosis cases in the community (the MI-TB study)$387,291
R01 · FY2020 · AI
The Missing Millions: Identification and infectiousness of undiagnosed tuberculosis cases in the community (the MI-TB study)$342,146
R01 · FY2022 · AI
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$113,400
K43 · FY2019 · TW
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$113,400
K43 · FY2021 · TW
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$113,400
K43 · FY2022 · TW
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$113,400
K43 · FY2020 · TW
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$113,400
K43 · FY2018 · TW
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$80,957
K43 · FY2021 · TW